Skip to content
NeuroDeRisk
NeuroDeRisk
Neurotoxicity De-Risking in Preclinical Drug Discovery
  • Home
  • Consortium
    • Consortium Partners
    • Scientific Advisory Board
  • Neurotoxicity
  • in silico Toolbox
  • News
  • Q & A
  • Contact
  • Search
  • Home
  • Consortium
    • Consortium Partners
    • Scientific Advisory Board
  • Neurotoxicity
  • in silico Toolbox
  • News
  • Q & A
  • Contact
  • Search
First Consortium Meeting
WP 4 – Coordination Meeting
Press Release: NeuroDeRisk – Cracking the code of neurotoxicity

Press Release: NeuroDeRisk – Cracking the code of neurotoxicity

October 22, 2019 April 29, 2022
Download the PDF

 NeuroDeRisk | Press Release

Academic Project Coordinator

Thierry Langer, University of Vienna

EFPIA – Project Leader

Jacques Richard, Sanofi

Join NeuroDeRisk.EU on

 

The NeuroDeRisk project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821528.
This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Innovative Medicines Initiative
European Union
EFPIA
  • Imprint-
  • Disclaimer-
  • Privacy Policy-
Back to Top

© NeuroDeRisk